Pro-MMP-9 is associated with poor prognosis in gastric cancer

Yukihiro Nomura Department of Physiological Chemistry and Metabolism, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; Department of Surgery, Asahi General Hospital, Chiba, Japan

Kunika Takasaki Department of Physiological Chemistry and Metabolism, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; Department of Chemistry, College of Engineering, Kanto Gakuin University, Yokohama, Japan

Masakazu Tada Department of Physiological Chemistry and Metabolism, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan

Masataka Yoshimoto Department of Surgery, Breast Center, Mita Hospital, International University of Health and Welfare, Tokyo, Japan

Hideyuki Ishida Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan

Nobuo Murata Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan; Department of Surgery, Mizonokuchi Hospital, Teikyo University School of Medicine, Kawasaki City, Kanagawa, Japan

Shunichiro Kubota Department of Physiological Chemistry and Metabolism, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; Department of Life Sciences, Graduate School of Arts and Sciences, University of Tokyo, Komaba, Tokyo, JapanCorrespondence[email protected]

, MD show all

References

Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJ. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. Br J Cancer 1998; 78: 1495–502
PubMed Web of Science ®Google Scholar
Sier CF, Kubben FJ, Heerding MM, Griffioen G, Hanemaaijer R, van Krieken JH, et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996; 74: 413–7
PubMed Web of Science ®Google Scholar
Dragutinovic VV, Radovanovic NS, Izrael-Zivkovic LT, Vrvic MM. Detection of gelatinase B activity in serum of gastric cancer patients. World J Gastroenterol 2006; 12: 105–9
PubMedGoogle Scholar
Torii A, Kodera K, Uesaka T, Hirai T, Yasui K, Morimoto T, et al. Plasma concentration of matrix metalloproteinase 9 in gastric cancer. Br J Surg 1997; 84: 133–6
PubMedGoogle Scholar
Endo K, Maehara Y, Baba H, Yamamoto M, Tomisaki S, Watanabe A, et al. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer. Anticancer Res 1997; 17: 2253–8
PubMed Web of Science ®Google Scholar
Kubben FJ, Sier CF, Meijer MJ, van den Berg M, van der Reijden JJ, Griffioen G, et al. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer 2006; 95: 744–51
PubMedGoogle Scholar
Bramhall SR, Schulz J, Nemunaitis J, Brown PD, Baillet M, Buckels JA. A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer. Br J Cancer 2002; 87: 161–7
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Pro-MMP-9 is associated with poor prognosis in gastric cancer

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Pro-MMP-9 is associated with poor prognosis in gastric cancer

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date